| Atara Biotherapeutics, Inc. ATRA | $4.52B | 132.78 | 6.51M | +2,375.59% | +$4.34B | 2.58 | |
Perspective Therapeutics, Inc. CATX | $14.6B | 18.21 | 12.27M | New | +$14.6B | 8.35 | |
| Inhibrx Biosciences, Inc. INBX | $42.1B | 8.32 | 1.2M | +372.56% | +$33.19B | 24.07 | |
| American Well Corporation AMWL | $766.45M | 6.32 | 945,421 | -55.35% | -$950.04M | 0.44 | |
| Hess Corporation HES | $1.43B | 3.03 | 9.34M | +1,686.28% | +$1.35B | 0.82 |